MyFinsight
Home
Blog
About
Net income (loss)
$43,665K
(328.11%↑ Y/Y)
Prepaid expenses,
operating lease...
-$2,443K
(-217.17%↓ Y/Y)
Proceeds from maturities
of marketable...
$5,500K
(-78.43%↓ Y/Y)
Proceeds from the
issuance of common stock...
$121K
Proceeds from the
issuance of common stock...
$13K
(30.00%↑ Y/Y)
Share-based compensation
$424K
(-87.86%↓ Y/Y)
Loss on disposal of
assets
-$18K
Depreciation and
amortization
$2K
(-96.30%↓ Y/Y)
Net cash provided by
(used in) operating...
$45,919K
(347.09%↑ Y/Y)
Net cash provided by
investing activities
$5,500K
(-61.04%↓ Y/Y)
Net cash provided by
financing activities
$131K
(1210.00%↑ Y/Y)
Canceled cashflow
$633K
Net increase
(decrease) in cash and cash...
$51,550K
(1256.35%↑ Y/Y)
Accrued expenses, tax
liability and operating...
-$521K
(37.38%↑ Y/Y)
Accounts payable
-$107K
(32.70%↑ Y/Y)
Net accretion of
discounts/premiums on debt...
-$5K
(98.62%↑ Y/Y)
Back
Back
Cash Flow
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)
source: myfinsight.com